replacing a dopamine agonist by the comt-inhibitor  xxxd3395xxx  as an adjunct to l-dopa in the treatment of parkinson's disease: a randomized, multice...  this study investigated the feasibility, safety, and potential benefit in motor symptom control when switching from a dopamine agonist to  xxxd3395xxx  as an adjunctive therapy in patients with parkinson's disease with a fluctuating response to levodopa (l-dopa). we determined the efficacy of 2 replacement strategies.